Iraq gets first shipment of AstraZeneca vaccines via COVAX

Published 2021-03-25, 02:51 p/m
© Reuters. COVID-19 vaccine arrives in Baghdad
AZN
-

BAGHDAD (Reuters) - Iraq received 336,000 doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine on Thursday, the first sent there under the global COVAX vaccine-sharing scheme.

Health minister Hassan al-Tamimi came to Baghdad Airport to greet the life-saving shipment and watched as the cases were unloaded into refrigerated trucks. He said they would quickly go out to regions across the country.

Iraq got its first coronavirus vaccines - 50,000 doses of the Sinopharm doses donated by China - on March 2, but has struggled to keep up with demand.

It reported its highest ever daily tally of more than 6,500 new infections on Thursday, bringing the total to 815,605. Authorities have imposed a nightly curfew to try and contain the spread.

© Reuters. COVID-19 vaccine arrives in Baghdad

The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses for lower income countries by the end of 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.